Please login to the form below

Not currently logged in
Email:
Password:

Glyconics appoints CEO

Dr Kam Pooni joins the UK diagnostics firm

UK disease management diagnostics firm Glyconics has appointed Dr Kam Pooni as chief executive officer with immediate effect.

Dr Pooni succeeds current chief executive Dr Berwyn Clarke who becomes chairman, while Dr Mike Lewis moves from chairman to non-executive director.

With over 19 years experience in leading life science businesses, Dr Pooni joins Glyconics from Astellas Pharmaceutical Europe where he served as senior director of European commercial operations and effectiveness among other roles.

Dr Clarke said: “Kam is a proven leader, with an impressive combination of vision, passion and experience building and managing pharmaceutical businesses and will play a major role in the development of the business as well as bringing additional experience to the board.

“I look forward to working closely with him at this exciting stage of the company's development.”

11th November 2016

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....